First Trust Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-28,778
Closed -$481K 2357
2023
Q1
$481K Sell
28,778
-38,421
-57% -$619K ﹤0.01% 2146
2022
Q4
$1.04M Sell
67,199
-2,146
-3% -$33.2K ﹤0.01% 1952
2022
Q3
$1.03M Sell
69,345
-18,347
-21% -$303K ﹤0.01% 1983
2022
Q2
$1.44M Buy
87,692
+1,018
+1% +$17.5K ﹤0.01% 1842
2022
Q1
$1.74M Buy
86,674
+6,654
+8% +$138K ﹤0.01% 1824
2021
Q4
$2.03M Buy
80,020
+1,532
+2% +$39.5K ﹤0.01% 1786
2021
Q3
$2.12M Buy
78,488
+1,076
+1% +$30.8K ﹤0.01% 1756
2021
Q2
$2.24M Buy
77,412
+1,859
+2% +$51.4K ﹤0.01% 1763
2021
Q1
$1.99M Buy
75,553
+973
+1% +$27.6K ﹤0.01% 1729
2020
Q4
$2.14M Buy
74,580
+19,249
+35% +$512K ﹤0.01% 1542
2020
Q3
$1.32M Buy
55,331
+17,387
+46% +$401K ﹤0.01% 1611
2020
Q2
$793K Buy
+37,944
New +$748K ﹤0.01% 1843

Other funds holding BMEZ

First Trust Advisors's BMEZ Position: Q2 2023 in Review

First Trust Advisors sold out of BlackRock Health Sciences Trust II (BMEZ) in Q2 2023, closing a stake of 28,778 shares — an estimated $481K sold.

First Trust Advisors first reported a position in BMEZ in Q2 2020 and held it in 12 quarters. The position peaked at $2.24M in Q2 2021. 91 funds tracked by Wall St. Rank hold BMEZ as of Q2 2023.

  • First Trust Advisors reported no remaining BlackRock Health Sciences Trust II position as of Q2 2023 after selling out during the quarter.
  • First Trust Advisors sold 28,778 BlackRock Health Sciences Trust II shares in Q2 2023, an estimated $481K.
  • First Trust Advisors first reported a position in BlackRock Health Sciences Trust II in Q2 2020 and held it in 12 quarters.
  • First Trust Advisors's BlackRock Health Sciences Trust II position peaked at $2.24M in Q2 2021.
  • 91 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2023.

Based on First Trust Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.